The ATMA Advanced Psychedelic-Assisted Therapy (PaT) Certification Program is an advanced training program designed to prepare individuals to become psychedelic therapy providers. The program offers a practical and affordable approach to education and training through a world-class didactic curriculum, in-person coaching, and (possibly) participation in a Health Canada-approved clinical trial. Students will have the opportunity to embody the roles of the psychedelic guide and the participant, allowing for a deeper understanding of medicine from multiple perspectives. The program accepts new students every two months.
The program is designed to meet the increasing demand for trained psychedelic facilitators in Canada and the United States. Psychedelic therapy is quickly becoming recognized as a “breakthrough therapy” worldwide and is on the cusp of regulatory approval. In November 2020, Oregon voted to become the first U.S. state to legalize supervised psilocybin therapy services in controlled and professionally facilitated settings. Hundreds of mental healthcare professionals in and around those states will be seeking training in a relatively short period of time.
The program includes ten modules of online coursework with lectures from leading experts in the psychedelic realm, the opportunity to work online with an easy-to-navigate format, at an individual pace allowing for busy therapists and professionals to take this course without disruptions to their own practices, access to regular live sessions, including live Q&A sessions, with leading experts from their faculty, as well as guest presenters, regular assignments and assessments throughout the course to keep students engaged and motivated and clinical trial opportunities to gain experience in psychedelic medicines under the scientific standards of a clinical setting.
A lower-priced version of the course is available for remote learning to adhere to the criteria for the Oregon facilitation criteria (no experiential component).